| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |